Lars Valeur Køber

Lars Valeur Køber

Clinical Professor

Member of:

  • Internal medicine: Cardiology


Publication year:
All
221 - 230 out of 1,385Page size: 10
  1. 2022
  2. Published

    Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical Trial

    Omar, M., Jensen, J., Burkhoff, D., Frederiksen, P. H., Kistorp, Caroline Michaela Nervil, Videbæk, L., Poulsen, M. K., Gustafsson, Finn, Køber, Lars Valeur, Borlaug, B. A., Schou, Morten & Møller, J. E., 2022, In: Circulation: Heart Failure. 15, 3, p. E009156

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Effect of Empagliflozin on Multiple Biomarkers in Heart Failure: Insights From the Empire Heart Failure Trial

    Jensen, J., Omar, M., Kistorp, Caroline Michaela Nervil, Tuxen, C., Poulsen, M. K., Faber, Jens, Køber, Lars Valeur, Gustafsson, Finn, Møller, J. E. & Schou, Morten, 2022, In: Circulation: Heart Failure. 15, 8, p. 799-801 3 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  4. Published

    Effect of implantable cardioverter-defibrillators in patients with non-ischaemic systolic heart failure and concurrent coronary atherosclerosis

    Byrne, C., Ahlehoff, O., Elming, M. B., Pedersen, F., Pehrson, S., Nielsen, J. C., Eiskjær, H., Videbæk, L., Svendsen, Jesper Hastrup, Haarbo, J., Thøgersen, A. M., Køber, Lars Valeur & Thune, J. J., 2022, In: ESC heart failure. 9, 2, p. 1287-1293 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Effectiveness and safety of P2Y12inhibitors in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a nationwide registry-based study

    Godtfredsen, S. J., Kragholm, K. H., Leutscher, P., Jorgensen, S. H., Christensen, M. K., Butt, J. H., Gislason, Gunnar Hilmar, Køber, Lars Valeur, Fosbøl, Emil Loldrup, Sessa, Maurizio, Bhatt, D. L., Torp-Pedersen, Christian & Pareek, M., 2022, In: European Heart Journal: Acute Cardiovascular Care. 11, 9, p. 697–705

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score: Insights From DAPA-HF

    Butt, J. H., Dewan, P., DeFilippis, E. M., Biering-Sørensen, Tor, Docherty, K. F., Jhund, P. S., Kosiborod, M. N., Martinez, F. A., Bengtsson, O., Johansen, N. D., Langkilde, A. M., Sjöstrand, M., Vaduganathan, M., Solomon, S. D., Sabatine, M. S., Køber, Lars Valeur, Fiuzat, M. & McMurray, J. J. V., 2022, In: JACC: Heart Failure. 10, 8, p. 543-555

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF

    Docherty, K. F., Anand, I. S., Chiang, C. E., Chopra, V. K., Desai, A. S., Kitakaze, M., Verma, S., Vinh, P. N., Inzucchi, S. E., Køber, Lars Valeur, Kosiborod, M. N., Martinez, F. A., Bengtsson, O., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., Langkilde, A. M., Jhund, P. S. & McMurray, J. J. V., 2022, In: JACC: Asia. 2, 2, p. 139-153

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction A Post Hoc Analysis of the DAPA-HF Trial

    Butt, J. H., Dewan, P., Merkely, B., Belohlávek, J., Drozdz, J., Kitakaze, M., Inzucchi, S. E., Kosiborod, M. N., Martinez, F. A., Tereshchenko, S., Ponikowski, P., Bengtsson, O., Lindholm, D., Langkilde, A. M., Schou, M., Sjöstrand, M., Solomon, S. D., Sabatine, M. S., Chiang, C. E., Docherty, K. F. & 3 others, Jhund, P. S., Køber, Lars Valeur & McMurray, J. J. V., 2022, In: Annals of Internal Medicine. 175, 6, p. 820-830

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction

    Docherty, K. F., Ogunniyi, M. O., Anand, I. S., Desai, A. S., Diez, M., Howlett, J. G., Nicolau, J. C., O'Meara, E., Verma, S., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Lindholm, D., Martinez, F. A., Bengtsson, O., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., Langkilde, A. M. & 2 others, Jhund, P. S. & McMurray, J. J. V., 2022, In: JACC: Heart Failure. 10, 1, p. 52-64

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Efficacy of Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure According to Sex: Extended Follow-Up Study of the DANISH Trial

    Butt, J. H., Yafasova, A., Elming, M. B., Dixen, U., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Bruun, N. E., Eiskjær, H., Brandes, A., Thøgersen, A. M., Gustafsson, F., Egstrup, K., Hassager, C., Svendsen, J. H., Høfsten, D. E., Torp-Pedersen, C., Pehrson, S., Thune, J. J. & 1 others, Køber, Lars Valeur, 2022, In: Circulation. Heart failure. 15, 9, e009669.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study

    Kaltoft, M., Sigvardsen, P. E., Afzal, Shoaib, Langsted, A., Fuchs, A., Kühl, J. T., Køber, Lars Valeur, Kamstrup, P. R., Kofoed, Klaus Fuglsang & Nordestgaard, Børge, 2022, In: Atherosclerosis. 349, p. 166-174

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...19 20 21 22 23 24 25 26 ...139 Next

ID: 543423